All Sigma antibodies (GSS, GLRX5, GGT1, HNRNPA1) were selected based on Western blot validation (human tissue only) in the Human Protein Atlas (www.proteinatlas.org)
In a randomized, placebo-controlled study of 495 patients with intermittent claudication, 2 g/day of propionyl-L-carnitine for 12 months significantly increased maximal walking distance and the distance walked prior to the onset of claudication in patients whose initial maximal walking distance was less than 250 meters (m), but no effect was seen in patients who had an initial maximal walking distance greater than 250 m (65)
This failure mode is most common when vials are stored above 8C, subjected to freeze-thaw cycles, or punctured with non-sterile needles
doi: 10.1158/0008-5472.CAN-06-1278 60 LinEYLiJFBricardGWangWDengYSellersRet al
Safe, hygienic, and results-driven. Rohit K